Notice of Results and Investor Presentation
TheraCryf plc has announced that its final results for the year ended 31 March 2026 will be released on Monday, 28 September 2026, with a live investor presentation scheduled for 1:00 p.m. BST on the same day. The presentation, accessible via Investor Meet Company, will feature the Chief Executive Officer, Chief Financial Officer, and Chair, and will allow for questions to be submitted in advance or during the event. This announcement provides an update on the company's financial reporting schedule and engagement opportunities for shareholders.
Select text to share a quote on X · sign in to keep highlights & notes in your TCF notes
TheraCryf plc, the biotech company developing new medicines for addiction and other neuropsychiatric disorders, today announces that the Company's final results for the year ended 31 March 2026 will be released on Monday, 28 September 2026.
A live presentation of the results will be given at 1.00 p.m. BST on Monday, 28 September 2026, via Investor Meet Company by Dr Huw Jones, Chief Executive Officer, Toni Hänninen, Chief Financial Officer and Dr Alastair Smith, Chair.
The results presentation will be open to all existing and potential shareholders. Questions can be submitted up to 24 hours prior to the event via the Investor Meet Company dashboard or during the live presentations.
Investors who already follow TheraCryf plc on the Investor Meet Company platform will automatically be invited. New registrants can sign up for Investor Meet Company HERE.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.